pI: 8.4079 |
Length (AA): 400 |
MW (Da): 46048 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 5
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129330)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G05360 | protein KMS2 |
Arabidopsis thaliana | AT4G14950 | ER associated membrane protein KMS1 |
Brugia malayi | Bm1_09750 | RIKEN cDNA 4930579A11 |
Caenorhabditis elegans | CELE_Y37D8A.22 | Protein EPG-3 |
Cryptosporidium hominis | Chro.50471 | hypothetical protein |
Cryptosporidium parvum | cgd5_3820 | vacuole membrane protein, VMP1 like integral membrane protein |
Dictyostelium discoideum | DDB_G0285175 | TMEM49 family protein |
Drosophila melanogaster | Dmel_CG32087 | CG32087 gene product from transcript CG32087-RA |
Drosophila melanogaster | Dmel_CG32675 | Transport and Golgi organization 5 |
Echinococcus granulosus | EgrG_000125700 | vacuole membrane protein 1 |
Entamoeba histolytica | EHI_027530 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000125700 | vacuole membrane protein 1 |
Homo sapiens | ENSG00000062716 | vacuole membrane protein 1 |
Leishmania braziliensis | LbrM.28.0740 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_280760.1 | SNARE associated Golgi protein, putative |
Leishmania infantum | LinJ.28.0760 | hypothetical protein, conserved |
Leishmania major | LmjF.28.0710 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.28.0710 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05994 | hypothetical protein |
Mus musculus | ENSMUSG00000018171 | vacuole membrane protein 1 |
Neospora caninum | NCLIV_018930 | GI15163, related |
Oryza sativa | 9267646 | Os07g0571500 |
Oryza sativa | 4326431 | Os01g0778700 |
Plasmodium berghei | PBANKA_1301600 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1474600 | conserved Plasmodium membrane protein, unknown function |
Plasmodium knowlesi | PKNH_1244900 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_118610 | hypothetical protein, conserved |
Plasmodium yoelii | PY00265 | TDC1, putative |
Schistosoma japonicum | Sjp_0051720 | Transmembrane protein 49, putative |
Schistosoma japonicum | Sjp_0051690 | Transmembrane protein 49, putative |
Schistosoma mansoni | Smp_019980 | vacuole membrane protein |
Schmidtea mediterranea | mk4.020376.00 | Ectopic P granules protein 3 |
Trypanosoma brucei gambiense | Tbg972.11.9210 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.8060 | SNARE associated Golgi protein, putative |
Trypanosoma congolense | TcIL3000.11.8570 | SNARE associated Golgi protein, putative |
Trypanosoma cruzi | TcCLB.508815.80 | SNARE associated Golgi protein, putative |
Toxoplasma gondii | TGME49_244370 | TDC1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0480 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0480 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0480 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.0480 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y37D8A.22 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_244370 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.